Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.8, Iss.3, 2004-06, pp. : 177-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 351-358

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Molecular Targets for Systemic Lupus Erythematosus and Other Immune-Complex and T-Cell Mediated Autoimmune Diseases - Update

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 331-332

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Lupus Erythematosus and Other Autoimmune Diseases from Endogenous and Exogenous Agents: Unifying Theme of Oxidative Stress

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 6, 2003-09 ,pp. : 568-575

Bentham Science Publishers

Access to resources Recommend Favorite

B-Cell-Targeted Therapy for Systemic Lupus Erythematosus

By Sabahi Ramin Anolik Jennifer H.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1933-1948

Adis International

Access to resources Recommend Favorite

B cell depletion in systemic lupus erythematosus

By Leandro Maria J Ehrenstein Michael R

Clinical Medicine, Vol. 7, Iss. 1, 2007-01 ,pp. : 57-59

Royal College Of Physicians

Access to resources Recommend Favorite